MX9703365A - Derivados de carbohidrato. - Google Patents

Derivados de carbohidrato.

Info

Publication number
MX9703365A
MX9703365A MX9703365A MX9703365A MX9703365A MX 9703365 A MX9703365 A MX 9703365A MX 9703365 A MX9703365 A MX 9703365A MX 9703365 A MX9703365 A MX 9703365A MX 9703365 A MX9703365 A MX 9703365A
Authority
MX
Mexico
Prior art keywords
carbohydrate derivatives
polyferation
ch2oso3
nhso3
oso3
Prior art date
Application number
MX9703365A
Other languages
English (en)
Other versions
MXPA97003365A (es
Inventor
Constant Adriaan Anton Boeckel
Pieter Westerduin
Original Assignee
Akzo Nobel Nv
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Sa filed Critical Akzo Nobel Nv
Publication of MX9703365A publication Critical patent/MX9703365A/es
Publication of MXPA97003365A publication Critical patent/MXPA97003365A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se refiere a derivados de carbohidratos que tienen la formula I, en donde R1 es H o CH2OSO3; R2 y R3 son independientemente H, alquilo (1-6C), o SO3; R4 es OSO3, o NHSO3; n es 0 o 1; p es 1 o 2; o una sal farmacéuticamente aceptable del mismo. Los compuestos de la invencion tiene actividad antitrombotica y pueden ser utilizados para inhibir la proliferacion de células del musculo liso.
MXPA/A/1997/003365A 1996-05-08 1997-05-08 Derivados de carbohidrato MXPA97003365A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201267.0 1996-05-08
EP96201267 1996-05-08

Publications (2)

Publication Number Publication Date
MX9703365A true MX9703365A (es) 1998-06-30
MXPA97003365A MXPA97003365A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
CA2204204A1 (en) 1997-11-08
ATE215547T1 (de) 2002-04-15
CA2204204C (en) 2006-02-28
CN1115345C (zh) 2003-07-23
HU9700852D0 (en) 1997-06-30
BRPI9703099B1 (pt) 2016-07-19
PT818459E (pt) 2002-08-30
EP0818459A3 (en) 1998-04-29
AR007052A1 (es) 1999-10-13
KR100443802B1 (ko) 2004-10-08
BRPI9703099A (pt) 1998-09-08
HUP9700852A2 (en) 1997-12-29
DK0818459T3 (da) 2002-07-01
NO972120D0 (no) 1997-05-07
IL120722A (en) 1999-07-14
HU226370B1 (en) 2008-09-29
HK1004399A1 (en) 1998-11-27
PL183469B1 (pl) 2002-06-28
CZ292439B6 (cs) 2003-09-17
EP0818459B1 (en) 2002-04-03
SG46779A1 (en) 1998-01-20
SG55310A1 (en) 1998-12-21
ID17932A (id) 1998-02-12
JP4201360B2 (ja) 2008-12-24
TR199700354A3 (tr) 1997-11-21
NO308251B1 (no) 2000-08-21
RU2183638C2 (ru) 2002-06-20
BRPI9703099B8 (pt) 2021-07-06
HUP9700852A3 (en) 1998-08-28
ES2176609T3 (es) 2002-12-01
TR199700354A2 (xx) 1997-11-21
PL319843A1 (en) 1997-11-10
ZA973892B (en) 1998-08-19
EP0818459A2 (en) 1998-01-14
CN1169433A (zh) 1998-01-07
CZ138697A3 (cs) 1998-02-18
TW498078B (en) 2002-08-11
DE69711505D1 (de) 2002-05-08
US5872110A (en) 1999-02-16
KR19980018097A (ko) 1998-06-05
JPH1045805A (ja) 1998-02-17
AU2008697A (en) 1997-11-13
AU711630B2 (en) 1999-10-21
DE69711505T2 (de) 2002-09-26
NO972120L (no) 1997-11-10
IL120722A0 (en) 1997-08-14
NZ314745A (en) 1998-09-24

Similar Documents

Publication Publication Date Title
SI0641767T1 (en) Cytotoxic stilbene derivatives and pharmaceutical composition containing them
MY101748A (en) Novel 8-chloro-1, 5-benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions.
NZ196250A (en) Imidazole derivatives and pharmaceutical compositions
AU572978B2 (en) 1,5-benzothiazepine derivatives
ES8802148A1 (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
UA49089C2 (uk) Похідні вуглеводів та фармацевтична композиція на їх основі
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
CA2204204A1 (en) Carbohydrate derivatives
UA37311C2 (uk) Засіб для лікування статевої дисфункції і фармацевтичний препарат
DE3567651D1 (en) Novel 1,5-benzothiazepine derivative, processes for preparing the same and pharmaceutical compositions
ES8702390A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina
GB2129425B (en) 5-halovinyl-2'-deoxyuridine derivatives
DE3666223D1 (en) Anticonvulsant agents
SG4595G (en) Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.
MX9704548A (es) Compuestos peptidomesticos antiherpes.